FR2444465A1 - Procede de production d'une preparation thrombolytique - Google Patents

Procede de production d'une preparation thrombolytique

Info

Publication number
FR2444465A1
FR2444465A1 FR7836125A FR7836125A FR2444465A1 FR 2444465 A1 FR2444465 A1 FR 2444465A1 FR 7836125 A FR7836125 A FR 7836125A FR 7836125 A FR7836125 A FR 7836125A FR 2444465 A1 FR2444465 A1 FR 2444465A1
Authority
FR
France
Prior art keywords
urokinase
thrombolytic preparation
production
molecular weight
preparation containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7836125A
Other languages
English (en)
Other versions
FR2444465B1 (fr
Inventor
Tadakazu Suyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Priority to FR7836125A priority Critical patent/FR2444465A1/fr
Publication of FR2444465A1 publication Critical patent/FR2444465A1/fr
Application granted granted Critical
Publication of FR2444465B1 publication Critical patent/FR2444465B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6462Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21073Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procédé de production d'une préparation thrombolytique contenant comme constituant principal une urokinase ayant une masse moléculaire de 54 000 +- 10 000. Parmi les conditions de traitement de la production de l'urokinase, le pH est maintenu dans le domaine neutre ou faiblement alcalin sur toute la durée de chaque stade du traitement pour produire une préparation thrombolytique contenant de l'urokinase ayant une masse moléculaire de 54 000 + 10 000 comme ingrédient principal. Application en médecine.
FR7836125A 1978-12-22 1978-12-22 Procede de production d'une preparation thrombolytique Granted FR2444465A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7836125A FR2444465A1 (fr) 1978-12-22 1978-12-22 Procede de production d'une preparation thrombolytique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7836125A FR2444465A1 (fr) 1978-12-22 1978-12-22 Procede de production d'une preparation thrombolytique

Publications (2)

Publication Number Publication Date
FR2444465A1 true FR2444465A1 (fr) 1980-07-18
FR2444465B1 FR2444465B1 (fr) 1984-11-16

Family

ID=9216456

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7836125A Granted FR2444465A1 (fr) 1978-12-22 1978-12-22 Procede de production d'une preparation thrombolytique

Country Status (1)

Country Link
FR (1) FR2444465A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519021A1 (fr) * 1981-12-28 1983-07-01 Takeda Chemical Industries Ltd Procede de stabilisation de la serrapeptase, composition contenant cette serrapeptase stabilisee et preparation de cette composition

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49125584A (fr) * 1973-04-11 1974-12-02
FR2258396A1 (fr) * 1974-01-22 1975-08-18 Green Cross Corp
JPS5120596A (fr) * 1974-08-11 1976-02-18 Hitachi Maxell
JPS5135481A (ja) * 1974-09-18 1976-03-25 Fujiwa Kako Kk Kojundohitorokinaaze no seiho
FR2291983A1 (fr) * 1974-11-20 1976-06-18 Abbott Lab Purification de l'urokinase
JPS52105279A (en) * 1976-03-01 1977-09-03 Wakamoto Pharma Co Ltd Collfcting method of urokinase and novel absorbing agent used in said method
US4066506A (en) * 1976-10-08 1978-01-03 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Method of separating and purifying two active forms of urokinase using affinity chromatography
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49125584A (fr) * 1973-04-11 1974-12-02
FR2258396A1 (fr) * 1974-01-22 1975-08-18 Green Cross Corp
JPS5120596A (fr) * 1974-08-11 1976-02-18 Hitachi Maxell
JPS5135481A (ja) * 1974-09-18 1976-03-25 Fujiwa Kako Kk Kojundohitorokinaaze no seiho
FR2291983A1 (fr) * 1974-11-20 1976-06-18 Abbott Lab Purification de l'urokinase
JPS52105279A (en) * 1976-03-01 1977-09-03 Wakamoto Pharma Co Ltd Collfcting method of urokinase and novel absorbing agent used in said method
US4066506A (en) * 1976-10-08 1978-01-03 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Method of separating and purifying two active forms of urokinase using affinity chromatography
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ABJP/79 *
CA1975 *
CA1976 *
CA1977 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519021A1 (fr) * 1981-12-28 1983-07-01 Takeda Chemical Industries Ltd Procede de stabilisation de la serrapeptase, composition contenant cette serrapeptase stabilisee et preparation de cette composition

Also Published As

Publication number Publication date
FR2444465B1 (fr) 1984-11-16

Similar Documents

Publication Publication Date Title
FR2613581B1 (fr) Procede de production de plants greffes de vegetaux ligneux ou semi-ligneux pour l'obtention de plants, notamment de vigne, et plants obtenus
FR2393795A1 (fr) Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique
TNSN94105A1 (fr) Composes sulfonamides tricycliques utiles pour l'inhibition de la fonction proteine g et pour le traitement des maladies proliferatives
DZ513A1 (fr) Produit protéinique d'expression et de traitement par un micro-organisme et son procédé d'obtention.
PT64840A (fr) Procede de preparation d'esteres aralquiliques d'acide 1,4-dihydrapiridinocarboxilique a effet coronaire et antihypertensive application des memes pour la preparation de compositions pharmaceutiques a effet coronaire et antihypertensive et application de ces compositions pharmaceutiques pour le traitement de maladies de lacirculation sanguine
FR2455027A1 (fr) Esters d'acylcarnitines utiles comme medicaments, leurs procedes de preparation et compositions therapeutiques les contenant
FR2556349B1 (fr) Procede perfectionne pour inhiber la croissance de micro-organismes dans un latex aqueux et produit obtenu
FR2546536B1 (fr) Procede pour le traitement de nappes non tissees et produit obtenu
FR2440371A1 (fr) Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
FR2418805A1 (fr) Polymeres organiques contenant du germanium utilisables comme medicaments et procede pour les preparer
FR2591892B1 (fr) Association collagene/principe actifantiseptique et/ou anti-inflammatoire a titre de composition, son procede de preparation et son utilisation pour la fabrication d'une composition pharmaceutique
FR2405258A1 (fr) Procede de preparation et de purification du facteur citrovorum par ouverture de noyau d'imidazoline et nouveau produit ainsi obtenu
FR2399836A1 (fr) Procede de preparation de produits biocompatibles et articles ainsi obtenus
BE833313A (fr) Nouveaux derives d'acide fusidique, utiles notamment comme anti-inflammatoires pour le traitement de l'arthrite, et leur procede de preparation
FR2444465A1 (fr) Procede de production d'une preparation thrombolytique
BG60013B2 (bg) Метод за производство на самоносещи керамични тела
FR2441639A1 (fr) Polymeres, procede pour leur preparation et agents de traitement de l'arteriosclerose contenant de tels polymeres
FR2515518B1 (fr) Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant
FR2457292A1 (fr) Purification de riboflavine
PT84697A (fr) Procede pour la preparation de compositions pour le traitement de la calvitie et des alopecies contenant phenytoine et diazoxyde
CA2126241A1 (fr) Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation
BE905332A (fr) Nouvelles substances antibiotiques et antitumorales, procede pour leur obtention et isolation; compositions pharmaceutiques les contenant.
OA07839A (fr) Procédé de traitement de l'huile de café et produit obtenu.
FR2407929A1 (fr) Nouveaux derives de 4-amino-2-(piperazin-1-yl ou homopiperazin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant
KR920700285A (ko) 플라즈미노겐 활성인자의 변형

Legal Events

Date Code Title Description
ST Notification of lapse